Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

LON/0HUZ stock hub

LON/0HUZ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HUZis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

7.8M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HUZ

In the news

Latest news · LON/0HUZ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-256.4

P25 -54.2P50 2.1P75 13.7

ROIC-136.1

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HUZ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

151

Groups with data

Currency

USD

Showing 151 of 151 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	25
Employees Change	-8%
Employees Change Percent	-24.24
Enterprise value	$2.1M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biotechnology
Isin	US15117N7012
Last refreshed	2026-05-10
Market cap	$7.8M
Price	$0.88
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	lon/0HUZ
Website	https://imunon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-137.54%
EV Earnings	-0.2x
EV/FCF	-0.2x
FCF yield	-134.52%
P/B ratio	1.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-10.8M
Net Income Growth Quarters	4%
Net Income Growth Years	2%
Profit Per Employee	$-430,792
ROA	-83.22
Roa5y	-49.73
ROCE	-191.2
ROE	-256.4
Roe5y	-139.8
ROIC	-136.1

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-90.16%
Cagr3y	-76.01%
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$9.1M
Cash	$6.5M
Current Assets	$7.9M
Current Liabilities	$3.4M
Debt	$749,512
Debt Equity	$0.14
Debt FCF	$-0.07
Equity	$5.2M
Liabilities	$3.9M
Long Term Assets	$1.3M
Long Term Liabilities	$491,453
Net Cash	$5.8M
Net Cash By Market Cap	$73.75
Net Cash Growth	64.2%
Net Debt Equity	$-1.1
Tangible Book Value	$5.2M
Tangible Book Value Per Share	$1.53
WACC	14.35

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.32
Net Working Capital	$-1.7M
Quick ratio	1.9
Working Capital	$4.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-93.23%
Dividend per share	$0
Last Dividend	$1.92

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-90.21%
200-day SMA	13.79
3Y total return	-98.62%
50-day SMA	11.32
50-day SMA vs 200-day SMA	50under200
All Time High	821.7
All Time High Change	-99.89%
All Time High Date	2020-06-24
All Time Low	0.88
All Time Low Change	0%
All Time Low Date	2025-01-29
ATR	0.66
Beta	2.09
Ch YTD	-92.33
High	0.99
High52	47.4
High52 Date	2024-07-30
High52ch	-98.14%
Low	0.88
Low52	0.88
Low52 Date	2025-01-29
Low52ch	0%
Ma50ch	-92.23%
Price vs 200-day SMA	-93.62%
RSI	48.52
RSI Monthly	29.87
RSI Weekly	41.26
Sharpe ratio	0.6x
Sortino ratio	1.43
Total Return	-93.23%
Tr YTD	-92.33
Tr1m	-91.46%
Tr1w	-92.29%
Tr3m	-92.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-10.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,539,060%
Shares Insiders	0.86%
Shares Institutions	6.03%
Shares Qo Q	-0.61%
Shares Yo Y	93.23%
Short Ratio	1.6

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.7M
Average Volume	224.85x
Bv Per Share	1.53
CAPEX	$-208,465
Ch1m	-91.46
Ch1w	-92.29
Ch1y	-90.21
Ch3m	-92.77
Ch3y	-98.78
Ch6m	-94.16
Change	-5.44%
Change From Open	-11.1
Close	0.93
Days Gap	6.37
Depreciation Amortization	214,118.6
Dollar Volume	475.3
Earnings Date	2026-05-12
EBIT	$-10.9M
EBITDA	$-10.7M
EPS	$-5.07
F Score	2
FCF	$-10.5M
FCF EV Yield	-495.35x
Financing CF	12,694,518
Fiscal Year End	December
Founded	1,982
Investing CF	-208,465
Is Primary Listing	0
Last Earnings Date	2025-11-05
Last Report Date	2025-12-31
Last Split Date	2022-03-01
Last Split Type	Reverse
Ma150	14.71
Ma150ch	-94.02%
Ma20	11.65
Ma20ch	-92.45%
Net CF	2,160,861
Next Earnings Date	2026-05-12
Open	0.99
Position In Range	0
Ppne	1,110,813.1
Price Date	2025-01-29
Ptbv Ratio	1.49
Relative Volume	2.4x
Share Based Comp	168,226
Tr6m	-94.16%
Volume	540

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0HUZ pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0HUZ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HUZ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+6.0%

Share of float held by funds and institutions

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HUZ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.5

Neutral momentum band

Price vs 200-day MA

-93.6%

50/200-day relationship not available

Beta (5Y)

2.09

More volatile than the market

Sharpe ratio

0.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HUZ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HUZ stock rating?

lon/0HUZ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HUZ analysis?

The full report lives at /stocks/lon/0HUZ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HUZ?

The latest report frames lon/0HUZ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HUZ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.